INVENTIVA: Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux
January 24, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused ...
Atossa Therapeutics, Inc.: Atossa Therapeutics Issues Letter to Shareholders Highlighting ...
Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...